We observed that LNMAS exerted an inhibitory effect on lymphangiogenesis in vitro and in vivo (Fig. 2H, J, D) by reducing VEGFC derived from cancer cells (Fig. 4C–E). The gene discussed is VEGFC; the disease is cancer.